Intent to Sole Source - Olink Reagents

SOL #: NOI-CC-OLAO-26-006363Special Notice

Overview

Buyer

Health And Human Services
National Institutes Of Health
Bethesda, MD, 20892, United States

Place of Performance

Bethesda, MD

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 11, 2026
2
Action Date
Jun 21, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute of Health, Clinical Center (NIH-CC) has issued a Notice of Intent to award a sole source contract to Olink Proteomics Inc. for Olink Reagents. This notice is not a request for proposal. Olink Proteomics Inc. is identified as the sole manufacturer of reagents compatible with their proprietary Q100 Instrument, which exclusively validates Olink reagents.

Scope of Requirement

The requirement is for reagents specifically designed for use with the Olink® Q100 Instrument. Olink Proteomics Inc. is the only company that manufactures and sells these compatible reagents. The NIH-CC has determined that no other vendor can supply the necessary reagents, making Olink Proteomics Inc. the only responsible source.

Contract & Timeline

  • Type: Special Notice - Intent to Sole Source
  • Statutory Authority: 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (only one responsible source)
  • Set-Aside: None (sole source justification)
  • Response Due: June 21, 2026, by 12:00 PM Eastern Standard Time
  • Published: June 11, 2026
  • Place of Performance: Bethesda, MD, United States

Action Items

This is not a request for proposal. However, all responsible sources capable of providing the required reagents may submit a capability statement for consideration. Submissions should be sent via email to valerie.gregorio@nih.gov with the subject line NOI-OLAO-CC-26-006363. The Government will consider all responses received by the closing date, but the determination not to compete this requirement remains solely at the Government's discretion.

People

Points of Contact

No contacts available

Files

Files

Download
Download

Versions

Version 1Viewing
Special Notice
Posted: Jun 11, 2026
Intent to Sole Source - Olink Reagents | GovScope